Share your organization’s discoveries with high visibility and impact

Most Taylor & Francis titles—across all subject areas—have an open access publishing option, including many of our leading MEDLINE-indexed medical and pharmaceutical journals.

With open access, researchers in your organization can benefit from:

  • High visibility and discoverability of research
  • Rapid online publication
  • Dialogue with expert editors and editorial boards
  • Rigorous peer review
  • Freedom to share important work while retaining copyright
  • Legacy preservation of articles
  • Compliance with mandates for transparency and openness
Looking for guidance before you submit?

We're happy to take questions about your open access submission

We offer open access publication in selected medical and pharmaceutical journals for the competitive article publishing charge (APC) of £3,925/$4,995/€4,555. Payment of the APC guarantees that the research will always be freely and permanently available, and copyright will be retained by the author under a CC-BY-NC-ND license.

Publication is subject to rigorous, independent peer review; we uphold the highest standards of ethical publishing and comply with ICMJE, COPE, and GPP-3 guidelines.

Want to learn more about open research at Taylor & Francis?

Open access can also be combined with Accelerated Publication, so your important findings can reach the widest possible audience in as little as 3 weeks from submission. Read more about Accelerated Publication.

Choose a journal

The medical and pharmaceutical journals featured below offer open access and Accelerated Publication.

Open access padlock icon - gold
Ready to submit?

From your chosen journal's homepage, follow the Instructions for Authors to submit your open access article.


Interested in a Taylor & Francis journal not listed here? A full, searchable list of titles offering open access options can be found on our Author Services site.